December 2, 2014: ACTTION Submits Letter of Intent to FDA for QUALITE-Pain

ACTTION has been assigned a Drug Development Tool number by FDA and submitted a Letter of Intent to FDA to begin development of the “QUALIfied for Therapeutic Evaluations of Pain” (QUALITE-Pain) instrument and then apply for its qualification as a Clinical Outcome Assessment. ACTTION is eagerly waiting for the FDA’s response and looks forward to developing an evidence-based and state-of-the-art approach for the assessment of pain intensity.

News

ACTTION Guide to Clinical Trials of Pain Treatments

The ACTTION Guide to Clinical Trials of Pain Treatments consists of two supplements published in the journal Pain Reports that include a series of articles describing research designs and methods, study conduct, outcome measures, data analyses and interpretation, and reporting recommendations for clinical trials of acute and chronic pain treatments.

Part I includes 9 articles that can be found here, and Part II includes 6 articles that can be found here.